LFB, in the spotlight on French news broadcast
To meet growing patient demand, at LFB, we have invested more than 700 million euros in the construction of our new production site in Arras. Thanks to this new biomanufacturing plant, which will open at the end of this year, we will be able to triple our plasma fractionation capacity, and therefore significantly increase our production of medicines.
Plasma donations in France are still below our needs. To meet this public health challenge, it is vital to collect more plasma in France, and thus reinforce the health sovereignty of France in plasma-derived medicines.
See the report on France 2 : France 2, JT 20h du 4 février 2024